Vanderbilt Eye Institute

November 14, 2013

Vision research group names VU graduate student to its board

Vanderbilt graduate student Megan Capozzi has been named the Member-In-Training Board of Trustee to the Association for Research in Vision and Ophthalmology (ARVO).

By Jessica Pasley
October 31, 2013

Penn named to vision group’s scientific advisory panel

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.

By Jessica Pasley
September 27, 2013

Metabolic profiling of vision loss

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.

By Leigh MacMillan
September 19, 2013

Team tracking new options to treat glaucoma

Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.

By Jessica Pasley
August 15, 2013

Glaucoma patients focus of Sousan’s sharing nature

Suzanne Sousan is not afraid of much.

By Jessica Pasley
August 8, 2013

Glasses bring girl’s world back in focus

Once upon a time, teenage girls were not clamoring to sport a pair of thick, black, oversized eyeglasses.

By Jessica Pasley
July 25, 2013

Grant to support blindess research

Research to Prevent Blindness (RPB) recently awarded a $110,000 grant to Vanderbilt’s Department of Ophthalmology and Visual Sciences in support of research into the causes, treatment and prevention of blinding diseases.
By Jessica Pasley
July 25, 2013

‘Bionic eye’ new option for retinitis pigmentosa patients

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
By Jessica Pasley
July 17, 2013

Vanderbilt ophthalmologist stresses summer eye safety

By Jessica Pasley
June 26, 2013

Insights on glaucoma gene mutations

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.
By Leigh MacMillan
March 7, 2013

Penn seeks new look at eye disorder

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated.
By Jessica Pasley
February 20, 2013

Last Days of Winter Can be Hard on Eyes; Vanderbilt Ophthalmologist Offers Care Tips

Winter may be slowly giving way to spring, but the remaining cold days of the season can cause plenty of trouble for the eyes—trouble that is largely avoidable, says a Vanderbilt Eye Institute ophthalmologist.
By Jessica Pasley
February 14, 2013

NIH lauds Rex’s ideas for future of vision research

Tonia Rex, Ph.D., assistant professor of Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute, was recently named one of 10 winners of the National Institutes of Health competition for ideas on the future of vision research.
By Jessica Pasley
1 … 7 8 9 10 11